Phase I/II Trial of Nonpegylated Liposomal Doxorubicin, Cyclophosphamide, Vincristine, and Prednisone in the Treatment of Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma-Reference-Cited by-同舟云学术

Phase I/II Trial of Nonpegylated Liposomal Doxorubicin, Cyclophosphamide, Vincristine, and Prednisone in the Treatment of Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma

Published:2006-07 Issue:1 Volume:7 Page:59-64
ISSN:1557-9190
Container-title:Clinical Lymphoma and Myeloma
language:en
Short-container-title:Clinical Lymphoma and Myeloma

Author:

Tulpule Anil,Espina Byron M.,Berman Nancy,Buchanan Laura H.,Smith D. Lynne,Sherrod Andy,Dharmapala Dharshika,Gee Conway,Boswell William D.,Nathwani Bharat N.,Welles Lauri,Levine Alexandra M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference21 articles.

1. Non-Hodgkin's lymphomas;Rosenberg,1993

2. Long term remission durability and functional status of patients treated for diffuse histiocytic lymphoma with the CHOP regimen;Armitage;J Clin Oncol,1984

3. Comparison of standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma;Fisher;N Engl J Med,1993

4. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma;Coiffier;N Engl J Med,2002

5. Cord Blood-Derived T Cells Can Be Genetically Engineered to Be B-Lineage All-Specific: Towards Adoptive Immunotherapy after Umbilical Cord Blood Transplantation.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas;Cancers;2023-10-18

2. Coexistence of (CCND1/PRAD-1/BCL1) juxtaposition and drug resistance gene is a marker for vincristine-resistant B-non-Hodgkin’s lymphoma;The Egyptian Journal of Haematology;2019

3. TrkA is a binding partner of NPM-ALK that promotes the survival of ALK+T-cell lymphoma;Molecular Oncology;2017-06-18

4. Nonpegylated Liposomal Doxorubicin as a Component of R-CHOP Is an Effective and Safe Alternative to Conventional Doxorubicin in the Treatment of Patients With Diffuse Large B-Cell Lymphoma and Preexisting Cardiac Diseases;Clinical Lymphoma Myeloma and Leukemia;2015-08

5. Nanomedicine strategies for hematological malignancies: what is next?;Nanomedicine;2014-10